288 related articles for article (PubMed ID: 7562470)
1. Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
Cockcroft JR; Chowienczyk PJ; Brett SE; Chen CP; Dupont AG; Van Nueten L; Wooding SJ; Ritter JM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1067-71. PubMed ID: 7562470
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol: endothelium-mediated vasodilating effect.
Ritter JM
J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S13-6. PubMed ID: 11811387
[TBL] [Abstract][Full Text] [Related]
3. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
4. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
van Lieburg AF; Knoers NV; Monnens LA; Smits P
J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
[TBL] [Abstract][Full Text] [Related]
5. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo.
Seddon MD; Chowienczyk PJ; Brett SE; Casadei B; Shah AM
Circulation; 2008 Apr; 117(15):1991-6. PubMed ID: 18391107
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide mediated venodilator effects of nebivolol.
Bowman AJ; Chen CP; Ford GA
Br J Clin Pharmacol; 1994 Sep; 38(3):199-204. PubMed ID: 7826820
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
Prisant LM
J Clin Pharmacol; 2008 Feb; 48(2):225-39. PubMed ID: 18083889
[TBL] [Abstract][Full Text] [Related]
9. No-dependent vasodilation induced by nebivolol in coronary circulation is not mediated by beta-adrenoceptors or by 5 HT1A-receptors.
Chlopicki S; Kozlovski VI; Gryglewski RJ
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):615-24. PubMed ID: 12512696
[TBL] [Abstract][Full Text] [Related]
10. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension.
Dawes M; Brett SE; Chowienczyk PJ; Mant TG; Ritter JM
Br J Clin Pharmacol; 1999 Sep; 48(3):460-3. PubMed ID: 10510163
[TBL] [Abstract][Full Text] [Related]
11. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
Gupta S; Wright HM
Cardiovasc Ther; 2008; 26(3):189-202. PubMed ID: 18786089
[TBL] [Abstract][Full Text] [Related]
13. Exploring vascular benefits of endothelium-derived nitric oxide.
Cockcroft JR
Am J Hypertens; 2005 Dec; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
[TBL] [Abstract][Full Text] [Related]
15. Effects of nebivolol on human platelet aggregation.
Falciani M; Rinaldi B; D'Agostino B; Mazzeo F; Rossi S; Nobili B; Rossi F; Filippelli A
J Cardiovasc Pharmacol; 2001 Dec; 38(6):922-9. PubMed ID: 11707696
[TBL] [Abstract][Full Text] [Related]
16. Involvement of nitric oxide in both central and peripheral haemodynamic effect of D/L-nebivolol and its enantiomers in rats.
Sacco G; Evangelista S; Criscuoli M; Goso C; Bigioni M; Binaschi M; Manzini S; Maggi CA
Eur J Pharmacol; 2005 Mar; 511(2-3):167-74. PubMed ID: 15792785
[TBL] [Abstract][Full Text] [Related]
17. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
Greven J; Gabriëls G
Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
[TBL] [Abstract][Full Text] [Related]
18. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
19. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
Schindler C; Leuschner S; Schwanebeck U; Kirch W
J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
[TBL] [Abstract][Full Text] [Related]
20. Quantitative aspects of the inhibition by N(G)-monomethyl-L-arginine of responses to endothelium-dependent vasodilators in human forearm vasculature.
Dawes M; Chowienczyk PJ; Ritter JM
Br J Pharmacol; 2001 Nov; 134(5):939-44. PubMed ID: 11682440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
